SCHEMBL6774766

SCHEMBL6774766

CCc1cc(O)c2c3c(C(N)=O)cccc3n(Cc3cccc(C)c3)c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
ADRA1D P25100 1/20 0.42
PLA2G2A P14555 4/20 0.41
F10 P00742 2/20 0.40
PARP1 P09874 2/20 0.40
PARP2 Q9UGN5 2/20 0.40
MAPT P10636 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
THRB P10828 2/20 0.39
SRC P12931 1/20 0.39
PRKACA P17612 1/20 0.39
PRKACG P22612 1/20 0.39
PRKACB P22694 1/20 0.39
MAPK8 P45983 1/20 0.39
HPGD P15428 2/20 0.38
OPRM1 P35372 1/20 0.38
OPRD1 P41143 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6777696 0.90 PLA2G2A (0.47) PLA2G2APARP1
SCHEMBL6691732 0.90 ADRA1D (0.44) ALDH1A1MEN1KMT2AL3MBTL1ADRA1D
SCHEMBL6770304 0.89 CNR1 (0.42) ALDH1A1MEN1KMT2AL3MBTL1ADRA1D
SCHEMBL6693347 0.89 PLA2G2A (0.51) ALDH1A1MEN1KMT2AL3MBTL1ADRA1D
SCHEMBL6776827 0.88 PLA2G2A (0.53) ALDH1A1MEN1KMT2AL3MBTL1ADRA1D
SCHEMBL6777588 0.88 F10 (0.40) PLA2G2AF10PARP1PARP2MAPK8
SCHEMBL6774816 0.88 LMNA (0.43) L3MBTL1PLA2G2AF10MAPTMAPK8
SCHEMBL6889689 0.88 MAPT (0.47) ALDH1A1MEN1KMT2AL3MBTL1F10
SCHEMBL6777282 0.88 PLA2G2A (0.41) PLA2G2A
SCHEMBL6773912 0.88 PLA2G2A (0.45) PLA2G2AF10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6713645-B1 INHIBITING SPLA2 MEDIATED RELEASE OF FATTY ACIDS FOR TREATMENT OF CONDITIONS SUCH AS SEPTIC SHOCK ELI LILLY AND COMPANY 2004-03-30 US disclosed
US-6177440-B1 THERAPY FOR SEPSIS SHOCK; PHOSPHOLIPASE INHBITOR ELI LILLY AND COMPANY 2001-01-23 US disclosed
EP-0952149-A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors ELI LILLY AND COMPANY (US) 1999-10-27 EP disclosed